Bone marrow mesenchymal stem cells (BMSCs) can reduce alveolar macrophages (AM) apoptosis by downregulating the p-GSK-3b and β-catenin pathways in AMs, thus slowing ARDS caused by acute lung injury (ALI). This evidence concerns the gene GSK3B and acute respiratory distress syndrome.